Lv1
40 积分 2024-11-08 加入
Neurological disorders following the use of tumor necrosis factor-α inhibitors in inflammatory bowel disease patients: a real-world pharmacovigilance analysis
1个月前
已完结
Dose-dependent pancreatitis risk associated with GLP-1 agonists
1个月前
已完结
Inflammatory bowel disease associated with the combination treatment of nivolumab and metformin: data from the FDA adverse event reporting system
1个月前
已完结
Adverse event profile of ocular injury associated with JAK inhibitors in patients with rheumatoid arthritis: a disproportionality analysis
1个月前
已完结
The safety profile of usage of glucagon‐like peptide‐1 receptor agonists in pregnancy: A pharmacovigilance analysis based on the Food and Drug Administration Adverse Event Reporting System
2个月前
已完结
A pharmacovigilance study of FDA adverse events for sugammadex
2个月前
已完结
Glucagon-like peptide-1 receptor agonists and impaired gastric emptying: a pharmacovigilance analysis of the US Food and Drug Administration adverse event reporting system
2个月前
已完结
Associations of acute kidney injury with oral anticoagulants: a disproportionality analysis of the food and drug administration adverse event reporting system (FAERS) database
2个月前
已完结
Ultrasonographic prediction of early miscarriage
2个月前
已完结
Prediction of pregnancy loss by early first trimester ultrasound characteristics
2个月前
已完结
皖公网安备34019202002308
